QT Imaging Q1 2024 EPS $(0.33) Down From $(0.20) YoY; Revenue $1.362M Up From $8,000
$QTI
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
QT Imaging Q1 2024 EPS $(0.33) Down From $(0.20) YoY; Revenue $1.362M Up From $8,000
Save time and jump to the most important pieces.
424B3 - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)
10-Q - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)
8-K - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce participation at the Radiological Society of North America 2024 Annual Meeting, taking place in Chicago, December 1-5, 2024. Dr. Bilal Malik, Chief Science Officer, Dr. James Wiskin, Fellow, and Dr. Raluca Dinu, Chief Executive Officer, will represent QTI at the event. Dr. Bilal Malik will deliver a presentation on December 4th during the 9:30 am session on Breast Ultrasound Techniques. His talk titled: "Assessing Non-inferiority of quantitative transmission (QT) ultrasound imaging compared with digital breast to
Generated Scanner Sales Revenue of $0.9 Million with 65% Gross Margin in the Third Quarter of 2024 The Company Successfully Completed the Engineering and Clinical Feasibility Study with its Strategic Partner The Company Announced Entering into Favorable Amendments to Its $10 Million Convertible Promissory Note with YA II PN, Ltd. The Company Announced Insiders PIPE investment of $2.56 Million, fully funded by the QTI Board of Directors members and their Affiliates QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results
QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems (the "Company" or "QTI") is pleased to announce an insiders private investment in public equities (PIPE) investment of $1.0 million in new funding, led by the Chairman of the Board, Dr. Avi Katz, and the Chief Executive Officer, Dr. Raluca Dinu, with participation of an additional four QTI Board of Directors members (the "Investors"). In addition, one existing creditor of the Company managed by Dr. Katz, GigAcquisitions5, LLC, agreed to surrender to the Company and cancel a promissory note that it holds with a principal amount of $1.56 mi
Generated Scanner Sales Revenue of $0.9 Million with 65% Gross Margin in the Third Quarter of 2024 The Company Successfully Completed the Engineering and Clinical Feasibility Study with its Strategic Partner The Company Announced Entering into Favorable Amendments to Its $10 Million Convertible Promissory Note with YA II PN, Ltd. The Company Announced Insiders PIPE investment of $2.56 Million, fully funded by the QTI Board of Directors members and their Affiliates QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results
Generated Scanner Sales Revenue of $1.7 Million with 51% Gross Margin in the Second Quarter of 2024 The Company Continues to Make Progress in the Engineering and Clinical Feasibility Study with its Strategic Partner Signed a U.S. Exclusive Distribution Agreement Announced Partnership with the University of Oklahoma and OU Health Stephenson Cancer Center to Improve Precision in Cancer Detection and Treatment QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the second quarter of 2024. "QT Imaging's team comp
SC 13G - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)
SC 13D/A - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)
SC 13D/A - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)
Generated Scanner Sales Revenue of $1.4M with 56% Gross Margin in the First Quarter of 2024, Since the Company Became Public on March 4th Streamlined Business Model via Strategic Sales and Distribution Partnership in USA Reported in Academic Radiology the Results of a Second Blinded Screening Trial That Found That QTI Technology Is Similarly Effective as Digital Breast Tomosynthesis (DBT) or 3D Mammography Company Completed Merger with GigCapital5 QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the first qu
Shares of Chuy’s Holdings, Inc. (NASDAQ:CHUY) rose sharply in today's pre-market trading after the company and Darden Restaurants, Inc. (NYSE:DRI) jointly announced that Darden will acquire Chuy's Holdings. Chuy's Holdings and Darden entered into a definitive agreement in which Darden will acquire all of Chuy's outstanding stock for $37.50 per share in cash. The all-cash transaction has an enterprise value of approximately $605 million. Chuy’s Holdings shares jumped 47.4% to $37.27 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Onconetix, Inc. (NASDAQ:ONCO) gained 65% to $0.2458 in pre-market trading. On July 15, Onconetix announced cl